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MEDICATION ADHERENCE TECHNOLOGY:




Despite significant advances in medical technology, American doctors
face a growing problem the number of patients who do not take their
medication as directed.' This non-compliant behavior occurs in patients
with relatively minor medical issues as well as those with life threatening
conditions, and it has become a large and costly problem for American
health providers.2 In 2010, the New England Journal of Medicine reported
that patient non-compliance costs the healthcare system $100 billion per
year in additional hospital stays and results in thousands of preventable
deaths.3
Health Information Technology ("Health IT") companies are eager to
provide a solution to the problem. Some have developed innovative "smart
packaging"4 that alerts the patient's physician when a medicine bottle is
opened or a pill is pushed out of the blister pack.5 If no signal is received
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1. David M. Cutler & Wendy Everett, Thinking Outside the Pillbox-Medication
Adherence as a Priority for Health Care Reform, 362 NEw ENG. J. MED. 1553 (2010).
2. Idat 1553-54.
3. Idat 1553.
4. Anna Wilde Matthews, Beep! It's Your Medicine Nagging You, WALL ST. J., Feb.
28, 2010, http://online.wsj.com/article/SB100014240527487034316045750957713900
40944.html.
5. Id. A blister pack refers to a particular kind of packaging where the pills are
displayed through plastic attached to cardboard or another material. The pills are pushed
out through the back of the card. This kind of packaging is particularly effective for
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the physician can call the patient to remind him or her about the missed
pills.6 More advanced pill technology is also in development-specifically
through the use of ingestible microchips embedded in medication.7 These
microchips are designed to transmit a signal when the medication is ingested
or even metabolized.
Although this emerging technology has many beneficial uses, it also poses
a serious threat to patient privacy and can constitute invasive medical
surveillance. First, this Comment will discuss the recent emergence of
medication adherence technology and the privacy issues implicated by its
use. Next, this Comment will consider how courts are likely to react to
medication adherence technology. Finally, this Comment will discuss
several possible legal responses to the privacy concerns raised by medication
adherence technology.
II. MEDICATION ADHERENCE
The term "medication adherence", also called medication compliance,
indicates how closely a person's behavior complies with his or her doctor's
treatment instructions. 9 Failure to follow a doctor's instruction manifests
itself in a variety of forms.' 0 For example, the patient who never fills the
adherence purposes because it is apparent from looking at the pack whether the patient
has taken a particular day's worth of pills. See also William M. Glazer, New Tools for
Managing Non-adherence: Providers Recognize the Value of Compliance, but What Can
They Feasibly Do About It?, BEHAVIORAL HEALTHCARE (Apr. 1, 2010),
http://www.behavioral.net/article/new-tools-managing-non-adherence.
6. Matthews, supra note 4.
7. Clay Dillow, Chip in a Pill Tells Your Doctor When You Swallow Your Medicine




9. WORLD HEALTH ORG., ADHERENCE TO LONG-TERM THERAPIES: EVIDENCE FOR
ACTION 3 (2003), available at http://www.who.int/chp/knowledge/publications/
adherence report/en/.
10. Medication Adherence Could Get An EHR Boost, PHARM. COMMERCE,
http://pharmaceuticalcommerce.com/index.php?pg=legal regulatory&articleid= 1959&ke
yword=medication%20adherence-NCPIE-e-prescribing-MirixaPro-EHR (last visited Feb.
26, 2012).
2012 325
326 The Journal of Contemporary Health Law and Policy Vol. XXVIII:2
prescription he is given; the patient who fills it but never takes the pills; and
the patient who intends to take the pills faithfully but frequently forgets to
take them exhibit non-adherent behaviors.
A. Problems with Non-Adherence
Sometimes referred to as "America's Other Drug Problem,"l 2 misuse and
nonuse of prescription medications is rampant.' It is estimated that 54% of
American adults do not take their medication as instructed. 14 At the same
time, there is abundant evidence that failure to take medication as prescribed
can lead to a host of health issues.'5  According to the New England
Healthcare Institute, medication non-adherence is responsible for an
estimated $300 billion each year in health care expenditures,16 $100 billon of
that cost for hospitalizations that could otherwise be prevented by proper
medication use.17
Medication adherence is particularly a problem for the elderly population.
Surveys indicate that 90% of elderly Americans take one or more
prescription medications per week 8 and 41% take five or more a week.19
Complicated dosing regimens can increase the difficulties already faced by
aging patients, who often suffer from decreased eyesight or mobility.20
11. Id.
12. Public Policy & Adherence: Statistics, TALK ABOUT RX,
http://www.talkaboutrx.org/med-compliance.jsp#problem (last visited Feb. 23, 2012).
13. See id.
14. PHARM. COMMERCE, supra note 10.
15. CTR. FOR TECH. & AGING, TECHNOLOGIES FOR OPTIMIZING MEDICATION USE IN
OLDER ADULTS 13 (2009), http://www.techandaging.org/MedOpPositionPaper.pdf.
16. Id.
17. Experts Try To Fix Problem of Millions Who Don't Adhere to Prescriptions,
KAISER HEALTH NEWS (May 10, 2010), http://www.kaiserhealthnews.org/Daily-
Reports/2010/May/10/Unadherence.aspx.




Forgetfulness, confusion, or financial constraints can also make adherence
difficult.21 Whatever the cause of non-compliance, however, statistics show
that seniors who do not follow their medication regimens are 76% more
likely to suffer a "major decline in total health" than their peers who do.2 2
Besides the obvious harm to patients' health, non-adherence is
problematic for the health industry in general. Pharmaceutical companies,
insurance companies, and pharmacies lose potential profit for every pill not
purchased as a result of non-adherent behaviors.23 In response, the health
care industry is developing Health IT solutions to boost patient compliance.
B. Health IT as a Solution for Non-Adherence
To combat the growing problem of non-adherence, health providers are
developing some inventive solutions.24 Health IT, specifically technology
that can remind patients about their medications, is a possible solution to the
problem. In conjunction with health providers, several companies are
developing information technologies meant to improve patient adherence.25
Supporters of Health IT claim that it will make a positive improvement in
the medical field through its ability to reduce medical errors, such as those
caused by inaccurate drug coding or patients forgetting what medications
they are taking so the physician can avoid possible negative interactions.26
21. Id.
22. Seniors Not Taking Medications as Directed More Likely to Face Long-Term
Health Problems, Study Says, KAISER HEALTH NEWS (June 25, 2004),
http://www.kaisemetwork.org/daily reports/print-report.cfm?DR ID=24425&drcat=3.
23. Alexander S. Misono et al., Healthcare Information Technology Interventions to
Improve Cardiovascular and Diabetes Medication Adherence, 16 AM. J. OF MANAGED
CARE SP82, SP91 (2010).
24. The most immediate solutions include: 1) simplifying medication regimens by
decreasing the frequency of doses, 2) speaking with the patient to try to discover why
they are not taking the medication consistently-whether this is due to financial
problems, personal beliefs about medicine, etc.-and 3) suggesting reminder techniques,
such as setting an alarm. CTR. FOR TECH. & AGING, supra note 15, at 14.
25. New Frontier Emerging in Use of Packaging to Differentiate Pharmaceuticals,
HEALTHCARE PACKAGING (June 16, 2010), http://www.healthcarepackaging.com/
archives/2010/06/new frontier emerging in use o.php.
26. Daniel J. Gilman & James C. Cooper, There is a Time to Keep Silent and a Time
to Speak, the Hard Part Is Knowing Which Is Which: Striking the Balance Between
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Additionally, proponents argue that having patient information available
electronically will decrease the administrative costs of facilitating
communication between healthcare providers. 27 According to one report,
"[n]o aspect of Health IT entails as much uncertainty as the magnitude of its
potential benefits." 28 One of those benefits is its capability to significantly
increase patient adherence.
III. COMPLIANCE TECHNOLOGY: YOUR MEDICINE IS CALLING
A. Adherence Packaging
One of the ways pharmaceutical companies are trying to combat the
adherence problem is through pharmaceutical packaging. Clear directions
and a simple dosing schedule help make adherence easier for patients.29
This type of format is used today in many blister packs, 3 0 which generally
include calendars to indicate when pills should be taken. 3 1 These packs have
the added benefit of providing a clear visual for patients to keep track of
whether they have taken their pills.32
A more recent development in the pharmaceutical packaging industry is
the use of electronic packaging. 33 The electronic age is opening up new
avenues for promoting adherence with novelties such as blinking pill bottles
or text messages that alert patients when it is time to take their medication. 34
The newest electronic packages are even capable of storing information
Privacy Protection and the Flow of Health Care Information, 16 MICH. TELECOMM. &
TECH. L. REV. 279, 293-94 (2010).
27. Id. at 290.
28. Id. at 291.




33. Matthews, supra note 4.
34. Id.
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about the patient's adherence. 35 For example, some can record the time and
date the medication is opened.36
Moreover, many of the designs can electronically transmit the information
they gather.37 For example, the "GlowCap," a product designed by Express
Scripts Inc., is an electronic cap for the standard sized pill bottle.38 Inside
the "GlowCap" is a wireless transmitter, which can automatically generate
emails to report the patient's adherence statistics. 39 If the patient does not
remember to take their medication, the pill bottle can send emails or text
messages to family members and the patient's doctor.40
B. "Smart" Pill Technology
Medication adherence technologies continue to become more
sophisticated. Although not currently available on the market,41 microchip
equipped pills-once only the purview of science fiction-are now being
42developed for general use. These pills, fitted with a tiny digestible
35. See, e.g., Joe Dysart, 'Take as Directed' a lot Easier with these New Tools, DRUG
Topics (Aug. 20, 2007), http://drugtopics.modemmedicine.com/drugtopics/
Top+News/Take-as-directed-a-lot-easier-with-these-new-tools/ArticleStandard/
Article/detail/450125.
36. Id. One of the most successful electronic compliance packages thus far is
Cerepak@, developed by MeadWestvaco Corporation. By way of a tiny microprocessor,
this blister pack records the time and date that each dose is taken. Information about
patient compliance can then by uploaded to a computer and examined by the prescribing
doctor. Cerepak@ Electronic Compliance Packaging, MWV,
http://www.meadwestvaco.com/HealthcarePackagingSolutions/AdherencePackaging/mw
v021872 (last visited Feb. 26, 2012).




41. One of these drugs, which may be ready for general use by 2012, is made by
Proteus Biomedical. Novartis AG, one of the largest pharmaceutical companies, recently
invested $24 million in the technology. Elizabeth Landau, Tattletale pills, bottles remind
you to take your meds, CNN HEALTH (Feb. 2, 2010), http://articles.cnn.com/2010-02-
02/health/pills.medication.compliance_1 _ill-adherence-cell-phone?_s=PM:HEALTH.
42. Dillow, supra note 7.
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microchip, will transmit a signal when they are ingested,43 allowing doctors
to remotely monitor patient adherence and collect a digital record of the
exact time the medication is taken.44
The possibilities for the technology seem endless. Already, researchers
are working on "smart pills" that can detect when they have been
metabolized and send a message to the doctor indicating that the medicine
45has entered the patient's bloodstream. Additionally, pills that can
automatically adjust how much medicine they administer, so as to provide
the optimal amount of medication for each particular patient, are also
forthcoming.46
The adherence technologies currently on store shelves and in development
are impressive, and the benefit to patients with adherence problems is
considerable. Many lives could be prolonged by improved adherence to
medication intended to address chronic and other serious conditions.4 7 The
technology has great potential to help those that want to take their
medication appropriately but have difficulty doing so.48 Moreover, in an
increasingly "wired" world, many people appreciate the convenience of
email, text messages, and alarm reminders.49 While these medical advances
could help doctors remotely monitor their patient's health and improve




45. CTR. FOR TECH. & AGING, supra note 15, at 16.
46. Id.
47. KAISER HEALTH NEWS, supra note 22.
48. CTR. FOR TECH. & AGING, supra note 15, at 14.
49. Matthews, supra note 4.
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IV. THE CURRENT STATE OF PRIVACY LAW
A. What is Privacy?
Although there is general agreement that a right to privacy exists, finding
an accurate definition of that right is far more difficult.50  The first
significant call for a privacy right came in 1890.51 In an article written for
the Harvard Law Review, Samuel D. Warren and Louis D. Brandeis urged
the U.S. Supreme Court to recognize a fundamental right of privacy to
protect "the sacred precincts of private and domestic life" from intrusion by
52 ,53others. Simply put, they argued that privacy is "the right to be let alone."
A year later the Supreme Court, in Union Pacific Railroad Company v.
Botsford, defined privacy as "the right of every individual to the possession
and control of his own person."54  Other posited definitions for privacy
include: 1) the right to control information,55 2) an autonomy regarding
personal matters, or, more abstractly, 3) "control over when and by whom
the various parts of us can be sensed by others."
B. Judicial Protection ofPrivacy Rights
Although a right to privacy does not appear expressly in the U.S.
Constitution, the Supreme Court has recognized privacy as a fundamental
right in certain situations. According to the Court, the right can be implied
from several provisions of the Bill of Rights, specifically the First, Third,
50. ADAM D. MOORE, PRIVAcY RIGHTS: MORAL AND LEGAL FOUNDATIONS 11 (Penn.
St. Univ. Press ed., 2010).




54. Union Pac. R.R. Co. v. Botsford, 141 U.S. 250, 251 (1891).
55. MOORE, supra note 50, at 13.
56. Id.
57. Id. at 25 (quoting Richard B. Parker, A Definition of Privacy, 27 RUTGERS L.
REV. 275, 280-81 (1974)).
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Fourth, Fifth, and Ninth Amendments. In a line of cases beginning with
Griswold v. Connecticut in 1965, the Supreme Court has held that privacy
against intrusion by the government is a constitutionally protected right.59
Supreme Court jurisprudence has primarily concerned two different kinds
of privacy.60 The first is a due process right to make certain personal
decisions without the government's intrusion. 61 The second, stated in the
Fourth Amendment, is the right "of the people to be secure in their persons,
houses, papers, and effects, against unreasonable searches and seizures." 62
The latter is the Constitutional right primarily implicated by adherence
technology.
1. Fourth Amendment Privacy Jurisprudence
Fourth Amendment protection is limited to the prevention of searches and
seizures by the government, most commonly performed by police.63  The
Amendment's protections are not triggered unless it is demonstrated that
there is a "reasonable expectation of privacy" where the privacy breach
64occurred. For example, the Court has held that a person may have a
58. Griswold v. Connecticut, 381 U.S. 479, 484 (1965).
59. Id; See also Eisenstadt v. Baird, 405 U.S. 438 (1972) (holding that there is a
right to be free from governmental intrusion into personal matters); Roe v. Wade, 410
U.S. 113, 153 (1973) (holding that "the Constitutional right of privacy is broad enough to
encompass woman's decision whether or not to terminate her pregnancy."); Lawrence v.
Texas, 539 U.S. 558 (2003) (holding that the Fourteenth Amendment protects personal
decisions "relating to marriage, procreation, contraception, family relationships, child
rearing, and education"); Cruzan v. Dir., Missouri Dep't of Health, 497 U.S. 261 (1990)
(holding that there is a constitutionally protected right to refuse medical treatment).
60. Mary Cheh, Technology and Privacy: Creating the Conditions for Preserving
Personal Privacy, in SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENTS & HUMAN RIGHTS
101 (Greece, 2001).
61. See, e.g., Loving v. Virginia, 388 U.S. 1 (1967) (recognizing a right to marry);
Cruzan, 497 U.S. at 261 (recognizing a right to decide to accept medical treatment);
Griswold, 381 U.S. at 479 (recognizing a right to decide whether to have children).
62. U.S. CoNsT. amend. IV.
63. Cheh, supra note 60.
64. Katz v. United States, 389 U.S. 347, 360 (1967) (Harlan, J., concurring)
(describing a "reasonable expectation of privacy").
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reasonable expectation of privacy within his own home,65 making a
warrantless search of the home generally unreasonable. 66
However, the privacy right is no longer protected if the information has
been exposed to the public. 67 Therefore, being in public as opposed to in the
home limits the Fourth Amendment's protections. For example, the Court
has held that a driver on a public street does not have a reasonable
expectation of privacy regarding the direction or destination of his
automobile.69 Consent of the person searched also makes a search lawful. 70
Injection or forced ingestion of a human with a microchip-equipped pill
could be considered an unlawful "search" under the Fourth Amendment
because it violates the right of the patient "to be secure in their person."71
However, this would only raise a constitutional issue if: (1) the "search" (use
of the pill) was not consensual, and (2) the search was conducted by the
government. This second requirement severely limits the applicability of the
Fourth Amendment to adherence technology because it appears that only
patients whose doctors are directly employed by the government and
working within the scope of their employment could recover for the invasion
of privacy.7 2 Additionally, a patient would have no cause of action against
third parties who use the gathered information inappropriately.73 Therefore,
it will not be effective to rely solely on constitutional guarantees of privacy.
In this case, it may be better for aggrieved plaintiffs to invoke the privacy
torts instead.
65. Silverman v. United States, 365 U.S. 505, 511 (1961).
66. Kyllo v. United States, 533 U.S. 27, 40 (2001).
67. Katz, 389 U.S. at 360.
68. Oliver v. United States, 466 U.S. 170, 181 (1984).
69. United States v. Knotts, 460 U.S. 276, 281 (1983).
70. Schneckloth v. Bustamonte, 412 U.S. 218, 219 (1973) (noting that the Fourth
Amendment is not violated if consent is given).
71. U.S. CONST. amend. IV.
72. Ferguson v. City of Charleston, 532 U.S. 67, 76 (2001) (holding that employees
at a state hospital are government actors for purposes of the Fourth Amendment).
73. Diane L. Zimmerman, Requiem for a Heavyweight: A Farewell to Warren and
Brandeis's Privacy Tort, 68 CORNELL L. REv. 291, 298 (1983).
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2. Privacy Torts
Historically, privacy protection unrelated to government action was
achieved through Common Law torts.74 Unlike the Fourth Amendment
right, state law privacy torts control third party behavior.75 First enumerated
after the publication of Warren and Brandeis' article, the Second
Restatement of Torts now recognizes four distinct causes of action that
protect different privacy rights. They are: (1) intrusion on seclusion, (2)
76publication of private facts, (3) false light, and (4) misappropriation.
The two privacy torts most relevant for purposes of this paper are
intrusion on seclusion and publication of private facts.n First, the intrusion
tort imposes liability for intentionally intruding "physically or otherwise
upon the solitude . . . of another or his private affairs or concerns."78 In
order to win a civil lawsuit based on this theory, the plaintiff must prove that
the intrusion would be "highly offensive to a reasonable person."7 9 Some
types of adherence technology-in particular the microchip equipped pills-
would likely meet this threshold requirement of being "highly offensive."
Other types of adherence technology could intrude upon the patient's
solitude if use of the medication was compulsory. Deciding whether to take
the medication is inherently a personal concern of the patient.so Many
people would undoubtedly find the intrusion to be highly offensive-who
really wants their doctor to know when they expel the microchip?
74. See Scott Jon Shagin, The Prosser Privacy Torts in a Digital Age, NEW JERSEY
LAWYER, THE MAGAZINE, 251-APR N.J. Law 9 (2008).
75. See Katz v. United States, 389 U.S. 347, 347 (1967) (observing that privacy
protection against third parties is left to state law).
76. Aaron Renenger, Satellite Tracking and the Right to Privacy, 53 HASTINGS L.J.
549, 556 (2002).
77. The false light tort will not adequately protect medical information privacy
because truth is a defense to the claim. The private records that need to be protected are
truly the patient's medical status. Id. Additionally, the misappropriation tort only applies
to embarrassing information about public figures so it would not protect the privacy of
the general public. Id at 557.




The second tort, publication of private facts, applies to information that is
not "of legitimate concern to the public."81 It requires that the publicized
information be of the kind that would be "highly offensive to a reasonable
person."82 However, the tort is limited in scope to those facts that are made
public. If private facts are not widely circulated, recovery may not be
available.
In addition to the state privacy torts just discussed, Congress has created
federal laws that protect privacy rights as well. Whether these laws will
make recovery possible for plaintiffs is addressed below.
C. Legislating Privacy Rights
Originally, privacy laws were enforced by the states. The states
administered tort protections through their judiciaries and frequentl enacted
statutes that enhance the protection given by the tort remedies.4 More
recently, however, the federal government has taken a larger role in the
protection of privacy.85  Federal legislation has the potential to provide a
81. RESTATEMENT (SECOND) OF TORTS § 652D (1977).
82. Id.
83. Id at § 652D cmt. A. William L. Prosser's well-known article in the California
Law Review describes the four kinds of privacy torts. Regarding publication of private
facts, Professor Prosser discusses the essential requirement that the facts be sufficiently
publicized. He states:
"It is an invasion of the right to publish in a newspaper that the plaintiff does
not pay his debts . . . but it has been agreed that it is no invasion to
communicate that fact to the plaintiffs employer, or to another individual, or
even to a small group, unless there is some . . . trust or confidential relation
which will afford an independent basis for relief."
Thus, while a doctor cannot publicize a patient's medical information without the
patient's consent, an ordinary citizen has no such professional duty of confidentiality. So
long as the disclosure does not pass the threshold of "publication", the harmed patient
will have no remedy in tort against them. William L. Prosser, Privacy, 48 CALIF. L. REV.
383, 393-394 (1960).
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strong national standard for privacy protection, but current federal law
appears to be insufficient because it provides few remedies for the person
harmed." In some cases, federal law even preempts state law that would
have provided a remedy to the injured.
The federal law most germane to the issue of health privacy is the Health
Insurance Portability and Accountability Act ("HIPAA"), passed by
Congress in 1996. 8 This law went into full effect in 2003, and provides that
entities covered by HIPAA must make electronic health information secure,
ensure that the information is disclosed properly,89 and limit the number of
people who have access to patient records. 90  HIPAA does not preempt
stronger protections in state law. 91 However, like many federal privacy
laws, although HIPAA provides for broad administrative agency
enforcement, it does not provide a remedy for individuals whose personal
information is compromised. 92
V. PRIVACY CONCERNS WITH ADHERENCE TECHNOLOGY
Health IT presents significant privacy concerns. Some patients might
object to private health information being transmitted, collected, and shared.
Medication that itself "tattle-tales" to family, caregivers, or other health
providers, can undermine personal autonomy and broadcast very personal
matters to others. The American legal system has traditionally protected
86. Id.
87. Id.
88. Id. at 15.
89. HIPAA recognizes the following as proper disclosures: 1) disclosure to the
patient, 2) disclosure for payment, treatment, or healthcare needs, 3) disclosure with
patient consent, and 4) disclosure based on an agreement. Michelle C. Pierre, Note, New
Technology, Old Issues: The All-Digital Hospital and Medical Information Privacy, 56
RUTGERS L. REv. 541, 551-552 (2004).
90. Understanding HIPAA Privacy: For Consumers, U.S. DEP'T OF HEALTH &
HUMAN SERVS., http://www.hhs.gov/ocr/privacy/hipaa/understanding/consumers/
index.html (last visited Feb. 26, 2012).
91. De Armond, supra note 84, at 16.
92. Joshua D.W. Collins, Toothless HIPAA: Searching for a Private Right of Action
to Remedy Privacy Rule Violations, 60 VAND. L. REV. 199, 201-202 (2007).
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personal medical decisions by competent adults.93  When and if to take
medications is a personal matter traditionally protected by the right to
privacy.94
A citizen's right to privacy is particularly important in the medical
context. Doctors, nurses, and other caregivers have a legal95 and ethical96
obligation to maintain the confidentiality of information supplied by their
patients.97 Americans must trust that their private medical information is
protected when they talk to their doctor.98 Without this security, some
patients may withhold essential information from their healthcare provider
fearing that the information will not remain private, and in doing so, risk
improper prescriptions and treatment.99
93. Cruzan v. Dir., Missouri Dep't of Health, 497 U.S. 261, 262 (1990) (holding that
there is a constitutionally protected right to refuse medical treatment); Vacco v. Quill,
521 U.S. 793, 805 (1997) (noting that the "overwhelming majority of state legislatures"
distinguish between allowing a patient to refuse treatment (which is legal) and physician-
assisted suicide (which is not)); Washington v. Harper 494 U.S. 210, 221-22 (holding that
a prisoner possesses "a significant liberty interest in avoiding the unwanted
administration of anti-psychotic drugs under the Due Process Clause of the Fourteenth
Amendment").
94. Cruzan, 497 U.S. at 262.
95. Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-
191, 110 Stat. 1936 (1996).
96. The traditional Hippocratic Oath was incorporated in Section IV of the American
Medical Association's Principles of Ethics. GEORGE J. ANNAS, THE RIGHTS OF PATIENTS:
THE AUTHORITATIVE ACLU GUIDE TO PATIENT RIGHTS 249 (3rd ed. 2004). Section IV
states "[a] physician shall respect the rights of patients, of colleagues, and of other health
professionals, and shall safeguard patient confidences within the constraints of the law."
AMA Code of Medical Ethics: Principles of Medical Ethics, Am. MED. Ass'N,
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-
ethics/principles-medical-ethics.page (last visited Feb. 23, 2012) [hereinafter AMA Code
ofMedical Ethics].
97. AMA Code of Medical Ethics, supra note 96.
98. Henriette Roscam Abbing, Medical Confidentiality and Electronic Patient Files,
19 MED. & L. 107 (2000).
99. Id.
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The recent explosion of Health IT has made confidentiality increasingly
more difficult to guarantee. The ease of gathering and transmitting medical
data allows more people access to health information 00 As Health IT use
increases, courts will likely see more litigation concerning medical privacy
that has been compromised.'oi
VI. PREDICTING JUDICIAL AND LEGISLATIVE RESPONSES TO HEALTH IT BY
ANALOGIZING TO OTHER CONTEMPORARY HEALTH INFORMATION
TECHNOLOGIES
As of now, the courts have not had occasion to consider adherence
technology, so the judicial response to its privacy implications is uncertain.
Until the particular issue of adherence technology is challenged in the
courts, it is helpful to look to other high profile information technology
areas, in particular Electronic Health Records and Radio Frequency
Identification Technology, to hypothesize what the judicial response may be.
A. Electronic Health Records and the Potential for Privacy Violations
Historically, patient medical records were written documents kept in the
physician's office.' 02 To access them, it was necessary to obtain the record
in person.103 Today, the widespread use of electronic health records means
that many doctors, pharmacists, and insurance providers have unscreened
access to an individual's medical record.104  Patients' personal health
information can be transferred online in seconds leading to possible privacy
encroachment. 0 5
100. Nicholas P. Terry & Leslie P. Francis, Ensuring the Privacy and Confidentiality
ofElectronic Health Records, 2007 U. ILL. L. REv. 681, 706 (2007).
101. Roger E. Harris, Note, The Need to Know Versus the Right to Know: Privacy of
Patient Medical Data in an Information-Based Society, 30 SUFFOLK U. L. REv. 1183,
1187-1188 (1997).
102. Id. at 1184.
103. Terry & Francis, supra note 100, at 705.
104. BONNIE F. FREMGEN, MEDICAL LAW AND ETHICS 223 (3d ed. 2009).
105. Pierre, supra note 89, at 547.
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1. Electronic Health Record Technology
There are many benefits to using electronic health records rather than
traditional paper records. Electronic records facilitate communication
between multiple providers, o0 alert physicians when they prescribe
incompatible medications, o7 and prevent medical errors as a result of
unclear handwriting.108  There is also evidence that the use of electronic
records can save healthcare providers a significant amount of money.109
Still, one of the largest drawbacks to electronic patient records is the
significant privacy concerns they create.11 0 Electronic records are more
difficult to protect than their paper counterparts.' Confidential patient
information can be hacked or inadvertently sent to the wrong person.112
Records can be accessed by individuals who are "snooping" public figures,
even though they may have no professional medical interest in the
information.1 13 Moreover, there is an issue concerning who owns these
medical records because the owner has control over how and when the
records can be accessed by others. In most states, the physician or hospital
owns the patient records they create, although patients may decide who else
receives access to them through written authorization.114
106. Terry & Francis, supra note 100, at 683.
107. Abbing, supra note 98, at 108.
108. Terry & Francis, supra note 100, at 683.
109. Gilman & Cooper, supra note 26, at 292.
110. Abbing, supra note 98, at 109.
111. Terry & Francis, supra note 100, at 706.
112. Id. at 705-06.
113. UCLA Medical Center suffered several high-profile security breaches in the past
few years in which employees have improperly accessed patient records-particularly
those of celebrities. Shaya Tayefe Mohajer, Ex-UCLA Researcher Pleads Guilty to
Record Breach, SEATTLE TIMES, Jan. 8, 2010, http://seattletimes.nwsource.com/html/
nationworld/2010746848 apusmedicalrecordsbreach.html.
114. FREMGEN, supra note 104, at 211; see also Estate of Finkle, 395 N.Y.S.2d 343,
344 (1977) ("[T]he vast majority of states hold 'that medical records are the property of
the physician or the hospital and not the property of the patient."'); Paul V. Steams,
Access to and Cost of Reproduction of Patient Medical Records: A Comparison of State
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2. Judicial Decisions Affecting Electronic Records
Judicial decisions on the subject of medical record ownership are
inconsistent. This confusion is partially a result of the 1977 Supreme Court
holding in Whalen v. Roe. 115 In Whalen, the Court seemed to announce a
right to information privacy, saying, "[t]he cases sometimes characterized as
protecting 'privacy' have in fact involved at least two different kinds of
interests. One is the individual interest in avoiding disclosure of personal
matters, and another is the interest in independence in making certain kinds
of important decisions."11 6  Despite this language, which appears to
recognize a Constitutional right to information privacy, the Court has not
addressed the issue further in the thirty years since the decision in Whalen.l17
Without additional guidance from the Supreme Court, lower courts have had
to interpret the meaning of information privacy on their own, and most of
those courts have held that the Constitution protects information privacy.119
Laws, 21 J. LEGAL MED. 79, 98 (2000) ("Historically, medical records belonged to the
hospital that treated the patient, or to the physician, if a private practitioner performed the
treatment.").
115. Brief for American Civil Liberties Union as Amici Curiae Supporting
Respondents at 7, NASA v. Nelson, 131 S. Ct. 746 (2011) (No. 09-530), available at
http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/09-530 RespondentAmCu
ACLU.pdf.
116. Whalen v. Roe, 429 U.S. 589, 598-600 (1977).
117. Lior Strahilevitz, The Centenarian Who Wasn't, NASA v. Nelson, and the
Constitutional Right to Privacy, UNIV. OF CHICAGO L. SCH. FACULTY BLOG (Sept. 23,
2010), http://uchicagolaw.typepad.com/faculty/strahilevitzlior/.
118. Brief for American Civil Liberties Union, supra note 115, at 8.
119. See, e.g., In Re Crawford, 194 F.3d 954, 958 (1999) (saying that the right to
information privacy "is firmly established"); Seaton v. Mayberg, 610 F.3d 530, 537
(2010) (recognizing and expanding the information privacy right found in Whalen);
Ramie v. City of Hedwig Village, Tex., 765 F.2d 490, 492 (1985) (recognizing the
information privacy right set out by the Supreme Court in Whalen). But see Am. Fed'n
of Gov't Emps., AFL-CIO v. Dep't of Hous. & Urban Dev., 118 F.3d 786, 791 (D.C. Cir.
1997) (noting that the D.C. Circuit does not recognize a constitutionally protected right to
information privacy); Bloch v. Ribar, 156 F.3d 673, 684 (6th Cir. 1998) (holding that
information privacy is only protected when another fundamental liberty interest is
involved).
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The Supreme Court had the opportunity to address the confusion in 2010
with its ruling in NASA v. Nelson.120 In Nelson, the Court was asked to
consider the constitutionality of certain questions in a government
background check required of all federal contractors working for NASA.121
The Court chose to decide the case narrowly on its facts, saying that the
background check was within the government's right as an employer, and
avoided making a broad constitutional ruling on information privacy.122 For
now at least, lower courts will continue to decide cases of information
privacy without the Supreme Court's guidance.
It is likely that the use of electronic medical records will continue to be an
important issue, as use of the technology is growing. By way of illustration,
consider the actions of the Obama administration, which allotted $36 billion
in federal stimulus money to facilitate the increased use of electronic
medical records.123 Intended to assist communications between multiple
providers, the significant amount of federal funding indicates that electronic
health records are here to stay.124 In addition to considering the judicial
response to electronic patient health records, and in an effort to better predict
the court's response to cutting edge Health IT, the judiciary's response to
Radio Frequency Identification technologies merits analysis as well.
B. Radio Frequency Identification Technology
Radio Frequency Identification ("RFID") is an electronic identification
system that uses microchips to identify tagged items.125 Like the UPC bar
120. Len Davidson, Opinion Analysis: Constitutional Issue Left Open, SCOTUSBLOG
(Jan. 19, 2011, 3:31 PM), http://www.scotusblog.com/?p= 112410.
121. Id.
122. Id. Nat'l Aeronautics and Space Admin. v. Nelson, 131 S. Ct. 746, 751 (2011)
(Alito, J., "[assuming] without deciding, that the Constitution protects a privacy right of
the sort mentioned in Whalen").
123. Sharing Medical Records Saves Lives, CONCORD MONITOR (Sept. 13, 2010),
http://www.concordmonitor.com/article/216160/sharing-medical-records-saves-lives.
124. Id.
125. Elizabeth G. Currid, More Bite Than Bark: The Legal and Social Consequences
of Microchipping Individuals with Alzheimer's Disease, 6 IND. HEALTH L. REv. 257, 359-
360 (2009).
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codes 12 6 found on everyday items but with more data storing capabilities,
RFID systems have been in use since the Second World War. Today
RFID is used in many areas including inventory control, shipment tracking,
and building security.128 During the 1990s, RFIDs were implanted in more
than fifty million of the world's domestic pets so that lost pets could be
identified and returned to their owners. 129
Today, the technology is FDA-approved for implantation in humans.1 3 0
VeriChip Corporation, the maker of the approved RFIDs, has made most of
its sales abroad-for example, the Mexican Attorney General and his staff
have all been injected with RFIDs to allow them to access high security
areas.131 Now, a new campaign by VeriChip is encouraging implantation in
"high-risk" Americans, particularly the elderly suffering from Alzheimer's
and children who are in danger of being kidnapped.132 Besides the
possibility of protecting "high-risk" people,133 other benefits of RFID
systems include the ability to manage assets, provide data for electronic
records systems, and prevent the distribution of counterfeit medications.1 34
Despite these benefits, the use of RFIDs in humans pose both health and
126. UPC codes, also known as bar codes, are vertical black and white stripe patterns
that appear on many consumer items. The bar code is read by a scanner which can
identify the data contained in the code. Bar Code Frequently Asked Questions (FAQ): Q.
What is a bar code?, Ass'N FOR AUTOMATIC IDENTIFICATION AND MOBILITY,
http://www.aimglobal.org/technologies/barcode/bcfaqs.asp (last visited Feb. 25, 2012).
127. RFID technology was first developed during World War II. The British used
RFIDs to identify their own aircraft. Currid, supra note 125, at 360.
128. Marisa Anne Pagnattaro, Getting Under Your Skin - Literally: RFID in the
Employment Context, 2008 U. ILL. J.L. TECH. & POL'Y 237, 237-240 (2008).
129. Id.




134. Radiation-Emitting Products: Radiofrequency Identification (RFID), U.S. FOOD
AND DRUG ADMIN., http://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/
ElectromagneticCompatibilityEMC/ucml 16647.htm (last visited Feb. 26, 2012).
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privacy risks. The FDA has cautioned that some RFID systems could
interfere with pacemakers and other electronic health devices. 135
Additionally, it has been widely reported that the implantable chips can
cause cancer and that both VeriChip and FDA officials overlooked testing
on lab rats that demonstrated this risk.136 Privacy concerns with RFIDs
focus primarily on the chips' power "to enhance the effectiveness of
surveillance-by governments . . . and by private parties both legitimate and
criminal." 37 RFID chips can function as a surveillance system because each
chip has a unique code.138 For example, if a customer purchases sunglasses
with a RFID chip inside for store inventory purposes, that chip effectively
could later be used to track the location of the person wearing the
sunglasses.139 Even more alarming for privacy advocates, RFID technology
has been inserted in all new U.S. passports since 2007.140 As a result, the
government can identify Americans abroad based on the locations of their
passports.141
Chips implanted in humans magnify the surveillance risk. While human
RFID chips are not currently programmed to track the whereabouts of their
"host," scientists are able to use the same kind of technology to track animal
135. Id.
136. Pagnattaro, supra note 128, at 245.
137. Katherine J. Strandburg & Douglas B. Burda, The Frontiers of Privacy Law:
Technology Marches On, 866 PLI/PAT 481, 490 (2006).
138. Id.
139. Id.
140. The U.S. Electronic Passport Frequently Asked Questions, U.S. STATE DEP'T,
http://travel.state.gov/passport/passport 2788.html#One (last visited Feb. 26, 2012); see
also, Letter from Laura Murphy et al., Director, American Civil Liberties Union, to Chief
of Legal Division, U.S. Office of Passport Policy (Apr. 4, 2005), available at
http://www.aclu.org/technology-and-liberty/aclu-comments-electronic-passports-state-
department.
141. See Matt Markovich, Is RFID Ready to Track People?, KOMONEWS.COM (Nov.
8, 2006), http://www.komonews.com/news/4594356.html.
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migration.142 Thus, the technology is available if someone wanted to track
individual humans. 143
Still, there are some ways to limit the tracking capabilities of RFID tags.
Beginning in August 2010, Wal-Mart stores began tagging clothing with
RFIDs to prevent shoplifting.'44 To minimize potential privacy concerns,
Wal-Mart attaches the tags to removable labels so that customers can
remove the RFIDs after they purchase the item.145 European retail stores
that use the technology generally remove the RFID enhanced tags at the
register.146 Nevertheless, while the tags can be removed, they cannot be
turned off and remain traceable.147
As of today, regulation of the technology has occurred almost exclusively
at the state level. 48 So far, fifteen states have passed RFID legislation.1
Wisconsin was the first state to completely ban the microchipping of
humans.o50 Other states have taken a more moderate approach; for example,
North Dakota passed a law that prevents required microchipping of humans
but allows microchipping if it is voluntary.15 California chose to put
142. Currid, supra note 125, at 364.
143. Id.






148. Currid, supra note 125, at 365.
149. The fifteen states that passed legislation are: Arkansas, California, Delaware,
Michigan, Nevada, New Hampshire, North Dakota, Oklahoma, Rhode Island, Texas,
Vermont, Virginia, Washington, Wisconsin, and Wyoming. SCOTT P. COOPER ET AL.,
PLIREF-PRIV, § 5:11 RADIO FREQUENCY IDENTIFICATION (2012).
150. Pagnattaro, supra note 128, at 247-249.
151. Id.
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limitations on various ways the chips could be used, including a ban on
employer-directed microchipping of their employees.1 52
VII. POSSIBLE JUDICIAL AND LEGISLATIVE RESPONSES TO ADHERENCE
TECHNOLOGIES
Because of the potential privacy threats associated with adherence
technology, the legal system needs to find the most effective ways to protect
patient privacy, while still allowing the use of adherence technology and its
many benefits. Legal responses could include a strict approach to traditional
consent law, 153 legislation to define parameters for adherence technology
use,154 improved electronic record privacy regulations, and a clear
position from the judiciary regarding the scope of the right to information
156
privacy.
A. Informed Consent Law: The Role of Doctors and Health Professionals
In legal terms, informed consent means that a person "allows something to
happen with full knowledge" of the risks and the possible alternatives to the
course of action. 157 A patient's informed consent is required before a doctor
may take certain actions or malpractice liability can result.
In the adherence technology arena, informed consent is essential and
could be strengthened and reinforced through federal legislation providing
for an explicit opt-in approach to the use of adherence technology.
Physicians would have to provide patients with documentation indicating the
potential privacy risks implicit in the technology and setting out the steps
152. Id.
153. Currid, supra note 125, at 379-380.
154. Id.
155. Pierre, supra note 89, at 552 (commenting that "HIPAA only begins to fill the
void in existing legislation for protecting medical information privacy").
156. Brief for American Civil Liberties Union, supra note 115, at 9.
157. BLACK'S LAW DICTIONARY 346 (9th ed. 2009).
158. Canterbury v. Spence, 464 F.2d 772 (1972) (holding that informed consent
happens when the patient exercises a choice with information about the possible
implications).
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taken to minimize those risks, including, for example: their system for data
storage, the accessibility of their electronic information, and how the
information is transferred to insurance companies and other providers. 159
Moreover, it is likely that medicines with built-in adherence technology will
be more expensive than traditional medications. Patients need to be fully
informed about this additional cost in order to make an informed decision
about whether to use adherence technology.
It is necessary to emphasize thatatients must be completely informed in
order to consent to the technology. Although it may be difficult to explain
some of the more complicated concepts-how a digestible microchip works,
for instance-health care providers have an ethical duty to keep patients
informed. 161
B. Potential Legislative Action
In addition to the legislative initiatives regarding informed consent,
additional legislation could enhance privacy protection. As mentioned
above, federal laws have historically had little effect on medical privacy;162
instead Congress has allowed individual states to determine the optimal level
of privacy necessary for its citizens' medical records.163 However, many
states have conflicting laws, making the state-based protection of electronic
records that are transferred across state lines particularly difficult.164
Because health providers often need to send electronic records interstate,
federal legislation becomes the most effective way to police those records
159. Kristen E. Edmundson, Global Positioning System Implants: Must Consumer
Privacy be Lost in Order for People to be Found?, 38 IND. L. REv. 207, 234 (2005).
160. See Moore, supra note 50, at 166.
161. Informed Consent, AM. MED. Ass'N, http://www.ama-assn.org/ama/pub/
physician-resources/legal-topics/patient-physician-relationship-topics/informed-
consent.shtml (last visited Feb. 25, 2012).
162. See supra Part IlI.C.
163. Pierre, supra note 89, at 557.
164. Catherine Louisa Glenn, Protecting Health Information Privacy: The Case for
Self-regulation of Electronically Held Medical Records, 53 VAND. L. REv. 1605, 1622
(2000).
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because it avoids the high costs associated with ensuring compliance with
the laws of many different states.'65
Like Electronic Health Records and RFIDs, adherence technology creates
a need for increased security. Congress has already taken an important step
to protect patient privacy protection by including medical privacy initiatives
in the American Recovery and Reinvestment Act. The Act included
provisions that strengthen HIPAA privacy rules and increase the fines that
the Department of Health and Human Services can levy against healthcare
providers for noncompliance.167 However, given that adherence technology
is in the early stages of development, it is unlikely that the privacy concerns
connected with its implementation were considered adequately at the time
that the legislation was passed; technology changes quickly while the
legislative process can be slow. Thus, HIPAA will continue to require
updating in order to address technology advances.
At the same time, individual states can pass legislation to provide many of
the same protections as HIPAA. Based on their police powers, states could
make their laws stricter than HIPAA and oversee the enforcement of those
privacy protections.168 For example, California's newly enacted privacy law
is a good model for legislation that punishes those who access medical
information without authorization.169 Califoia's law requires that health
providers protect patient records from unlawful access and enumerates a
165. As mentioned earlier, federal law has preempted many state privacy laws. When
broadening privacy legislation, total preemption should be avoided if possible because
state laws are the only ones providing remedies for individual plaintiffs. See De Armond,
supra note 84.
166. Kirsten Ruzic Wild, The Evolution of HIPAA: The Only Constant is Change, 12
J. HEALTH CARE COMPLIANCE 33 (2010).
167. Sheri Porter, Stimulus Package Includes New HIPAA Security Rules, AM. ACAD.
OF FAMILY PHYSICIANS (Mar. 18, 2009), http://www.aafp.org/online/en/home/
publications/news/news-now/government-medicine/20090318hipaa-security-rules.html.
168. Slaughter-House Cases, 83 U.S. 36, 62 (1872) (quoting Thorpe v. Rutland &
Burlington R.R. Co., 27 Vt. 140, 149 (1855)).
169. Two California laws which went into effect on January 1, 2009, significantly
increased the penalties for medical record "snooping." The new laws also require that
healthcare providers notify patients if their private medical information has been
improperly accessed. Edgar D. Bueno, New California Law Clamps Down on
Unauthorized Viewing of Medical Records, 10 PRIVACY AND INFO. L. REP. 6 (2009).
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series of penalties for providers who allow confidential medical information
to be breached. 170
Finally, in order to keep patient's health records private, federal
restrictions on mandatory use of the technology are needed. For example,
Congress can forbid the use of adherence promoting technology as a
prerequisite for insurance coverage, employment, or school admission.
Mandatory use of adherence technology would effectively nullify laws
requiring informed consent and result in patients only consenting because
they have no other choice.171 Additionally, Congress can pass legislation
requiring pharmaceutical companies to continue producing some
pharmaceuticals without adherence technology, so that patients who do not
want to use the technology may opt-out. Patients are not truly consenting if
their only option for receiving the benefits of a drug is to submit to
adherence technology. Finally, individuals who cannot readily assert their
rights or truly exercise informed consent-in particular the elderly, mentally
incompetent _atients, and children-should not be forced to use adherence
technology.17
C. Potential Judicial Action
Without specific legislation or an explicit contract term to interpret, the
judiciary will not be able to do much to prevent the misuse of medical
information technology. Still, courts will likely be asked to examine more
cases addressing Health IT and medical privacy as the use of the technology
grows. Americans have come to expect a certain level of privacy in their
lives and breaches of medical privacy will likely result in novel litigation
involving legal arguments which apply privacy law to Health IT."
In order to best protect patients, the Supreme Court should specifically
address the right of information privacy when the opportunity presents itself.
Some privacy scholars have argued that the Court should reexamine, and
reaffirm its declaration in Whalen v. Roe, recognizing information privacy as
170. JONES DAY, CALIFORNIA EXPANDS MEDICAL PRIVACY LAWS WITH NEW
STANDARDS, OVERSIGHT, AND ADMINISTRATIVE PENALTIES (2008), available at
http://www.jonesday.com/california-expands-medical-privacy-laws-with-new-standards-
oversight-and-administrative-penalties-12-03-2008/.
171. Moore, supra note 50, at 166.
172. Currid, supra note 125, at 383.
173. Harris, supra note 101, at 1187.
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a fundamental right. 174 This would allow patients better control over their
personal medical information, making recovery easier when a breach occurs
and encouraging health providers to handle confidential information more
carefully.
VIII. CONCLUSION
Adherence technology has the potential to improve the health of
Americans who have difficulty taking their medication properly.
"America's Other Drug Problem" is a serious public help issue and some
pharmaceutical companies are attempting to solve the problem.' 75 Besides
helping patients follow prescription regimens, Health IT may also reduce
medical errors, foster communication between a patient's multiple health
providers, and make administrative tasks easier. 76
And yet, Americans should be wary of any technology that makes highly
sensitive information about their health more readily available. Already
Electronic Health Records and RFIDs are becoming commonplace177 and
according to industry projections, pharmaceutical packaging demand will
reach $18.4 billion in the U.S. by 2014.178 Given all the advantages, many
of those products are likely to have built-in adherence technology.
The privacy issues related to adherence technology must be addressed
through legislative action on the state and national level. Patient privacy
laws such as HIPAA can be strengthened and updated in order to
specifically address these new technologies. Judicial action to further define
the medical privacy right is also needed. In the meantime, these
technological advances will ensure that medical privacy law continues to be
an important issue that all branches of the government-and all
Americans-should consider.
174. Pierre, supra note 89, at 571.
175. Public Policy & Adherence: Statistics, supra note 12.
176. Gilman & Cooper, supra note 26, at 281.
177. See, e.g., General RFID Information, Ass'N FOR AUTOMATIC IDENTIFICATION
AND MOBILITY, http://www.aimglobal.org/technologies/rfid/rfid-faqs.asp (last visited
Feb. 23, 2012).
178. Pharmaceutical Packaging Demand Forecast to Rise Through 2014,
HEALTHCARE PACKAGING (Sept. 9, 2010), http://www.healthcarepackaging.com/
archives/2010/09/pharmaceuticalpackagingdeman.php.
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